Yang Wang

Yang Wang has worked in the biotechnology industry since 2014. Yang began their career as a Research Scientist at Bristol-Myers Squibb in 2014. In 2015, they moved to Thermo Fisher Scientific, where they held the role of Scientist III/Technical Leader-BioProduction R&D. In 2018, they joined Solid Biosciences and held various roles up to Associate Director. In 2021, they became the Associate Director at Affinia Therapeutics.

Yang Wang holds a Doctor of Philosophy (PhD) in Bioprocess Engineering from the State University of New York College of Environmental Science and Forestry, an MS in Bioprocess Engineering from the same institution, and a BS in Applied Chemistry from Lanzhou University. In addition, they obtained a Six Sigma Green Belt certification from SigmaQuest Consulting, Inc. in 2011.